The February 2025 acquisition of Ambry Genetics further expands TEM's genomics capabilities with a West Coast lab and ...

The United States genetic testing market is poised for substantial growth, projected to expand from USD 4.71 billion in 2021 to approximately USD 12.08 billion by 2028, with a robust CAGR of 14.50%.

Tempus AI leverages AI for treatment decisions and diagnostics, thriving in the booming healthcare AI market with strong ...

Jonathan Bluth recently joined BGL as a managing director in the Healthcare & Life Sciences Investment Banking practice, one ...

Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...

Management guides for $1.24 billion in 2025 revenues, a 79% YoY growth, bolstered by the Ambry Genetics acquisition and a rapidly growing TAM. Despite the deep selloff recently, I rank TEM a ...

Artificial Intelligence (AI)-based healthcare solutions company Tempus AI TEM has continued to capture investors’ attention despite reporting weaker-than-expected fourth-quarter 2024 results on Feb.

ADHD likely has a genetic component. If a biological parent or sibling has ADHD, you’re more likely to have it, too, but this doesn’t mean you will. Your environment can be influential as well.

In February, TEM announced the completion of its acquisition of Ambry Genetics, a recognized leader in genetic testing that aims to improve health by understanding the relationship between ...

By Victor Mather A prince of Luxembourg has died at 22 of a genetic disease for which he spent his brief life raising awareness. Prince Frederik, the second cousin of the heir to the Luxembourg ...